US2012016105A1PendingUtilityA1

Purification of peptide conjugates by hydrophobic interaction chromatography

55
Assignee: DEFREES SHAWNPriority: Jan 8, 2004Filed: Jul 20, 2011Published: Jan 19, 2012
Est. expiryJan 8, 2024(expired)· nominal 20-yr term from priority
A61P 31/12A61P 43/00A61P 31/14A61P 31/22A61P 7/06A61P 3/10A61P 31/18A61P 35/00A61P 37/08A61P 7/00A61P 5/10A61P 35/02A61P 5/00A61P 31/20A61P 37/06A61P 5/06A61P 27/02A61P 25/00A61P 3/00A61P 25/14A61P 29/00A61P 25/20A61P 25/28A61P 13/00A61P 11/02A61P 17/02A61P 1/04A61P 15/08C07K 1/1077A61P 11/06A61P 19/10C07K 9/00A61K 38/193C07K 9/001A61P 13/12A61P 21/00A61P 1/16A61P 1/02C07K 14/535A61P 19/08A61P 19/02A61P 11/00
55
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides polypeptides that include an O-linked glycosylation site that is not present in the wild-type peptide. The polypeptides of the invention include glycoconjugates in which a species such as a water-soluble polymer, a therapeutic agent of a biomolecule is covalently linked through an intact O-linked glycosyl residue to the polypeptide. Also provided are methods of making a glycoconjugate, methods of isolating a glycoconjugate from a reaction mixture, pharmaceutical compositions containing a glycoconjugate, and methods of treating, ameliorating or preventing diseased in mammals by administering an amount of a glycoconjugate sufficient to achieve the desired response.

Claims

exact text as granted — not AI-modified
1 . A method of separating a covalent conjugate between a peptide and a modifying group from a reaction mixture, said method comprising:
 (a) contacting said reaction mixture with a hydrophobic interaction chromatography medium; and   (b) collecting said covalent conjugate from said hydrophobic interaction chromatography medium, thereby separating said covalent conjugate from said reaction mixture,   wherein said modifying group is covalently attached to said peptide at a glycosyl or amino acid residue of said peptide via an intact glycosyl linking group covalently attached to said glycosyl or amino acid residue by a glycosyltransferase.   
     
     
         2 . The method according to  claim 1 , wherein said modifying group is poly(ethylene glycol). 
     
     
         3 . The method of  claim 1 , wherein said peptide is Factor VIII. 
     
     
         4 . The method of  claim 2 , wherein said peptide is Factor VIII. 
     
     
         5 . A covalent conjugate between a peptide and a modifying group, wherein said covalent conjugate is obtained by a method comprising:
 (a) contacting a reaction mixture comprising said covalent conjugate with a hydrophobic interaction chromatography medium; and   (b) collecting said covalent conjugate, thereby separating said covalent conjugate from said reaction mixture, and   wherein said modifying group is covalently attached to said peptide at a glycosyl or amino acid residue of said peptide via an intact glycosyl linking group covalently attached to said glycosyl or amino acid residue by a glycosyltransferase.   
     
     
         6 . The covalent conjugate according to  claim 5 , wherein said modifying group is poly(ethylene glycol). 
     
     
         7 . The covalent conjugate of  claim 5 , wherein said peptide is Factor VIII. 
     
     
         8 . The covalent conjugate of  claim 6 , wherein said peptide is Factor VIII.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.